Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1432
| Despition | NENF Human Recombinant |
| SIZE | 2 µg |
| Purity | Purity as determined by densitometric image analysis is > 95%. |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1752 | Human ASPA Protein (AC1752) | 5 µg | inquiry |
| ACPP-1379 | Human OLFM1 Protein (AC1379) | 2 µg | inquiry |
| ACPP-1593 | Human MED7 Protein (AC1593) | 5 µg | inquiry |
| ACPP-1116 | Recombinant Human L1CAM Protein (6×His Tag) (AC1116) | 50 µg | inquiry |
| ACPP-1583 | Human NRTN Protein (AC1583) | 5 µg | inquiry |
| ACPP-1233 | Galectin 3 Blocking Peptide (AC1233) | 250 µg | inquiry |
| ACPP-1465 | Human CHRNA3 Protein (AC1465) | 5 µg | inquiry |
| ACPP-1771 | Human ATG3 Protein (AC1771) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.